Are Ind-Swift latest results good or bad?
Ind-Swift's latest results are concerning, showing an 11.90% decline in net sales and a significant drop in net profit of -233.82%, indicating operational challenges and reduced profitability in the third quarter of fiscal year 2024-25. Stakeholders should monitor the company's performance closely moving forward.
Ind-Swift has reported its financial results for the third quarter of fiscal year 2024-25, revealing a notable decline in key performance metrics. The company's net sales for the quarter ended December 2024 showed a decrease of 11.90% compared to the previous quarter, where it had experienced a growth of 19.76%. This shift indicates a challenging environment for the company in terms of revenue generation.Furthermore, the consolidated net profit also reflected a significant downturn, with a change of -233.82% compared to the previous quarter's -85.45%. This steep decline suggests that the company is facing substantial operational challenges that may impact its profitability.
In addition, the operating profit (PBDIT) excluding other income decreased by 49.13%, contrasting with a growth of 14.41% in the prior quarter. The operating profit margin, which stood at 6.10% in September 2024, also saw a reduction of 4.47%, indicating a tightening of operational efficiency.
Overall, these financial results highlight a difficult quarter for Ind-Swift, with a clear downward trend in both sales and profitability metrics. The company has experienced an adjustment in its evaluation, reflecting the current challenges it faces in the competitive pharmaceuticals sector. Stakeholders may want to monitor future developments closely as the company navigates this landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
